N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy

NCT01265563 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

108

Enrollment

FED

Sponsor class

Conditions

Diabetic Nephropathy
Proteinuria
Oxidative Stress

Interventions

DRUG: N-acetylcysteine placebo and silibin placebo
DRUG: N-acetylcysteine active and silibin placebo
DRUG: N-acetylcysteine placebo and silibin active
DRUG: N-acetylcysteine active and silibin active
DRUG: N-acetylcysteine active + high-dose silibin active

Sponsor

VA Office of Research and Development

Collaborators

[object Object]